Teladoc (NYSE: TDOC) saw its stock lose about half its value after announcing a $6.6 billion impairment charge amid a challenging integration of Livongo and its health management app. TDOC shares today are trading around $30 apiece, down 50% from where they were before yesterday’s Q1 earnings announcement. Teladoc closed its $18.5 billion purchase of […]